Kapil Saxena

5PUBLICATIONS
9CO-AUTHORS
Cellular immunologyGene and molecular therapyMolecular medicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
CD64 enables TCR-dependent, MHC-independent CTL cytotoxicity of AML cells.

|Mar 27, 2025
BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism.

Kapil Saxena, Shao-Hsi Hung, Esther Ryu

|Dec 23, 2024
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism.

Cassian Yee, Kapil Saxena, Esther Ryu

|Jun 25, 2021
A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia.

Kapil Saxena, Shelley M Herbrich, Naveen Pemmaraju

|Mar 20, 2021
New Treatment Options for Older Patients with Acute Myeloid Leukemia.

Kapil Saxena, Marina Konopleva

Pageof 1

Frequent Collaborators

1 joint publications

Naveen Pemmaraju

1 joint publications

Tapan M Kadia

1 joint publications

Courtney D DiNardo

1 joint publications

Elias Jabbour